Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1741-7015
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection ; volume:16 ; number:1 ; day:2 ; month:10 ; year:2018 ; pages:1-10 ; date:12.2018
BMC medicine ; 16, Heft 1 (2.10.2018), 1-10, 12.2018
- Creator
-
Fiala, Clare
- Contributor
-
Diamandis, Eleftherios P.
SpringerLink (Online service)
- DOI
-
10.1186/s12916-018-1157-9
- URN
-
urn:nbn:de:101:1-2018102223274398751397
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fiala, Clare
- Diamandis, Eleftherios P.
- SpringerLink (Online service)
Other Objects (12)
Circulating cell-free DNA and its clinical utility in cancer
Circulating tumor DNA: current implementation issues and future challenges for clinical utility
Utility of plasma circulating tumor DNA and tumor DNA profiles in head and neck squamous cell carcinoma
Liquid profiling – circulating nucleic acid diagnostics gains momentum
Utility of targeted deep sequencing for detecting circulating tumor DNA in pancreatic cancer patients
Implementing the ESMO recommendations for the use of circulating tumor DNA (ctDNA) assays in routine clinical application/diagnostics
Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapy
Three-dimensional imaging for hepatobiliary and pancreatic diseases: Emphasis on clinical utility
Circulating tumor DNA in Hodgkin lymphoma
The predictive utility of circulating PCSK9 levels on diabetes mellitus
Circulating tumor cells in breast cancer: clinical validity and utility
The utility of Next Generation Sequencing for molecular diagnostics in Rett syndrome
Circulating cell-free DNA and its clinical utility in cancer
Circulating tumor DNA: current implementation issues and future challenges for clinical utility
Utility of plasma circulating tumor DNA and tumor DNA profiles in head and neck squamous cell carcinoma
Liquid profiling – circulating nucleic acid diagnostics gains momentum
Utility of targeted deep sequencing for detecting circulating tumor DNA in pancreatic cancer patients
Implementing the ESMO recommendations for the use of circulating tumor DNA (ctDNA) assays in routine clinical application/diagnostics
Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapy
Three-dimensional imaging for hepatobiliary and pancreatic diseases: Emphasis on clinical utility
Circulating tumor DNA in Hodgkin lymphoma
The predictive utility of circulating PCSK9 levels on diabetes mellitus
Circulating tumor cells in breast cancer: clinical validity and utility
The utility of Next Generation Sequencing for molecular diagnostics in Rett syndrome
Circulating cell-free DNA and its clinical utility in cancer
Circulating tumor DNA: current implementation issues and future challenges for clinical utility
Utility of plasma circulating tumor DNA and tumor DNA profiles in head and neck squamous cell carcinoma
Liquid profiling – circulating nucleic acid diagnostics gains momentum
Utility of targeted deep sequencing for detecting circulating tumor DNA in pancreatic cancer patients
Implementing the ESMO recommendations for the use of circulating tumor DNA (ctDNA) assays in routine clinical application/diagnostics
Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapy
Three-dimensional imaging for hepatobiliary and pancreatic diseases: Emphasis on clinical utility
Circulating tumor DNA in Hodgkin lymphoma
The predictive utility of circulating PCSK9 levels on diabetes mellitus
Circulating tumor cells in breast cancer: clinical validity and utility